@FiercePharma: FDA nixes Endo petition to protect Opana ER from generics. Article | Follow @FiercePharma
> Irish drugmaker Elan ($ELN) snapped up a 21% share of Theravance ($THRX) royalties on a newly approved respiratory drug to be sold by GlaxoSmithKline ($GSK) in a $1 billion deal aimed at strengthening its defense against a buyout bid by Royalty Pharma. Report
> Vivus ($VVUS), under pressure from investors unhappy with its obesity drug marketing, has added two more directors to its board at a time when shareholder First Manhattan has proposed its own slate of 6 nominees. Report
> Two North Dakota men joined the hundreds who have sued Takeda Pharmaceutical, claiming the company's diabetes drug Actos caused their bladder cancer. Report
> GlaxoSmithKline and Save the Children teamed up in a 5-year, $23 million deal to improve healthcare and vaccination in the developing world. Report
Medical Device News
@FierceMedDev: Boston Scientific's Watchman AF device generates more stunning data. Story | Follow @FierceMedDev
@MarkHFierce: Swiss stent maker Bioensors Int'l will pay $51M for a U.S. imaging company - diversification program now under way. More | Follow @MarkHFierce
@DamianFierce: Glaxo is reaching into Hong Kong with a new DKSH partnership, targeting antibiotics. Article | Follow @DamianFierce
> Israel's budding medical device industry begins to flower. Item
> Sorin wins FDA nod for cardiac monitor. News
> Michigan State develops blood Dx for childhood malaria complication. DxExtra
Biotech News
@FierceBiotech: FDA accepts $BIIB's BLA for 1st long-lasting factor VIII therapy for hemophilia A. Release | Follow @FierceBiotech
@JohnCFierce: J&J gets a priority review for hep C drug simeprevir (with Medivir). More | Follow @JohnCFierce
@RyanMFierce: Mobile service PharmaSecure finds demand in losing fight against fake drugs. Story | Follow @RyanMFierce
> Vectura joins forces with a new JV biotech in China for respiratory therapies. News
> Class action suits pile up at Aveo's doorstep in wake of FDA debacle. More
> Elan pays $1B for a slice of Theravance's COPD franchise royalty stream. News
CRO News
> Argentine CRO Stat Research taps Datatrak. News
> Harlan Labs doubles in specialty research with U.S. expansion. Story
> PRA boosts informatics with Welsh expansion. More
> Quintiles hauls in $947M IPO after upping offering. Report
> AMRI piles on profits with strong Q2. Article
Biotech IT News
> Pfizer tests online Viagra sales to beat the cheats. News
> IT outfit Instem acquires Logos to penetrate early clinical trials market. More
> GlaxoSmithKline exec details expectations for online clinical trial research. Article
> Hong Kong billionaire backs Big Data effort in biomedicine at Oxford University. Story
> Pfizer opts to keep running Accelrys software in its labs. Article
And Finally... Scientists found a biomarker in patients' noses that may be linked to schizophrenia. Report